• BG IRIS Research Client Login
logo
logo
  • Transactions
  • Services
    • Overview
    • Solutions
    • Sector expertise
    • Research
  • Insights
    • Overview
    • White Papers
    • Blog
    • Reports
    • Client Focus
  • About us
    • Overview
    • Senior Team
    • News
    • Events
  • Careers
    • Overview
    • Early careers
    • Experienced hires
    • Employee Growth Stories
  • Media
    • Press
    • Videos
  • Contact
  • Search
  • BG IRIS Research Client Login

ECM

Bryan, Garnier & Co acts as Sole Placement Agent and Financial Advisor to Faron Pharmaceuticals on its convertible bond placement of up to €35.0 million

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Medincell, an innovative pharmaceutical company developing a portfolio of long-acting injectable products, on a EUR 42.9m Follow-on Offering

Bryan, Garnier & Co acts as Joint Bookrunner on Faron Pharmaceuticals' EUR 12 million Follow-On Offering

Bryan, Garnier & Co acts as Sole Financial Advisor on Median Technologies' EUR 10 million Bridge Financing

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Avantium, a leading renewable and circular plastics company, on a EUR 11.2m ABB

Bryan, Garnier & Co acts as Sole Financial Advisor, Joint Global Coordinator & Joint Bookrunner on Exact Therapeutics' NOK 145m Follow-On Offering anchored for USD 7m by GE Healthcare

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on ONWARD Medical's EUR 50m Follow-On Offering, anchored for EUR 22.5m by a Cornerstone Investment from Ottobock

Bryan, Garnier & Co acts as Sole Global Coordinator & Joint Bookrunner on Egetis Therapeutics' SEK 300 million Follow-On Offering

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Valneva's EUR 61.2m Follow-On Offering

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Cinclus Pharma's SEK 715m Nasdaq Stockholm IPO

  • 1
  • 2
  • 3
  • …
  • 15

Bryan, Garnier & Co

Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors.

CONTACT US
Latest News

  • BCI – Made in France 2025 – Hosted by Bryan, Garnier & Co
  • The Next Launch Window: What It Means for Satcoms
  • BG Growth Series – Avantium
  • Energy-Aware AI: Confronting the power-hungry reality of scaling AI
Quick links

Transactions

Insights

Senior Team

Information

Legal & Regulatory Information

Index 2025

Bryan Garnier Securities

Privacy Policy

Privacy Preference Center

Privacy Preferences

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }